DOSSIER · 13F Holders · Q3 2026
GTBP
GT Biopharma INC COM USD0.001(Rev Split)
6 institutions still hold GT Biopharma INC COM USD0.001(Rev Split) as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 36254L407·6 13F holders·last filed Sep 30, 2026
AI Holders Summary · Q3 2026
6 institutions reported GTBP in Q3 2026. Newbridge Financial Services Group, Inc. leads at 25.8% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.